Home
>
Stocks
>
Strides Pharma Science Limited

Strides Pharma Science Limited

STAR

298.85
0.21
(
0.07
%)
1D

Performance

Today's High
301.70
Today's Low
296.70
52W High
52.0
52W Low
52.0
Open Price
52.0
Prev. Close
52.10
Volume
52.0
Value
522 Cr.

Fundamentals

Market Cap
₹39,910Cr
P/E Ratio(TTM)
NA
P/B ratio
2.21
Industry P/E
-2.47
Debt to Equity
0.03
ROE
-10.01%
EPS(TTM)
-1.13
EPS(TTM)
-1.13
Book Value
25.84
Face Value
1

About

Strides Pharma Science Limited

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

ITC
2
HDFC Bank
2
Tata Consultancy Services
1
Top Gainers
Tata motors
1.28
SAIL
2.00
Gail
2.80
Top Losers
Britannia
-2
Adani
2